Junshi Biosciences' stock soared 8.66% during intraday trading on Monday, reflecting strong positive market sentiment.
The surge is attributed to the news that a major shareholder, Shanghai Tanying Investment, which held about 5.8% of the company, did not sell any shares as its planned reduction of up to 2% of the stake expired. This development alleviated concerns about potential selling pressure and was viewed as a positive signal regarding shareholder confidence.